Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4. - Wikidata - awgldk - TriplyDB

Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.

Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.

http://www.wikidata.org/entity/Q48190162

about

Connectivity of Pathology: The Olfactory System as a Model for Network-Driven Mechanisms of Alzheimer's Disease Pathogenesis Mutant alpha-synuclein exacerbates age-related decrease of neurogenesis.Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson's disease Primary age-related tauopathy (PART): a common pathology associated with human aging Tauopathic changes in the striatum of A53T α-synuclein mutant mouse model of Parkinson's disease.Olfactory dysfunction in LRRK2 G2019S mutation carriers Odor identification and progression of parkinsonian signs in older persons.Olfactory discrimination predicts cognitive decline among community-dwelling older adults.Olfaction in Parkinson's disease and related disorders.The relationship between cerebral Alzheimer's disease pathology and odour identification in old age.The effects of chronic alcoholism on cell proliferation in the human brain Olfactory dysfunction in fragile X tremor ataxia syndrome.Cortical Alzheimer type pathology does not influence tau pathology in progressive supranuclear palsy.Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer's disease with amygdala Lewy bodies.Reduced striatal tyrosine hydroxylase in incidental Lewy body disease.Genome-wide Meta-analysis on the Sense of Smell Among US Older Adults.Effects of bilateral deep brain stimulation of the subthalamic nucleus on olfactory function in Parkinson's disease patients.Increased Caspase-6 activity in the human anterior olfactory nuclei of the olfactory bulb is associated with cognitive impairment.TDP-43 in the olfactory bulb in Alzheimer's disease.Distinct Pattern of Microgliosis in the Olfactory Bulb of Neurodegenerative Proteinopathies.Neuropathology underlying clinical variability in patients with synucleinopathies.Olfactory dysfunctions in neurodegenerative disorders.Olfactory loss as a supporting feature in the diagnosis of Parkinson's disease: a pragmatic approach.Olfactory bulb involvement in neurodegenerative diseases.Increased amoeboid microglial density in the olfactory bulb of Parkinson's and Alzheimer's patients.Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders.Incidence and extent of Lewy body-related alpha-synucleinopathy in aging human olfactory bulb.Odor identification and decline in different cognitive domains in old age.Olfactory dysfunction: its early temporal relationship and neural correlates in the pathogenesis of Alzheimer's disease.Loss of olfactory tract integrity affects cortical metabolism in the brain and olfactory regions in aging and mild cognitive impairment.The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases.Odor identification and self-reported olfactory functioning in patients with subtypes of mild cognitive impairment.Interneurons, tau and amyloid-β in the piriform cortex in Alzheimer's disease.Interneurons and beta-amyloid in the olfactory bulb, anterior olfactory nucleus and olfactory tubercle in APPxPS1 transgenic mice model of Alzheimer's disease.A Card-type Odor Identification Test for Japanese Patients with Parkinson's Disease and Related Disorders.Alpha-synuclein pathology in the olfactory pathways of dementia patients.Hyposmia in progressive supranuclear palsy.Olfactory Dysfunctions and Decreased Nitric Oxide Production in the Brain of Human P301L Tau Transgenic Mice.Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease.Human Apolipoprotein E Genotype Differentially Affects Olfactory Behavior and Sensory Physiology in Mice.

P2860

Q26773114-8AFCC052-F38E-4AEC-B425-43856172AAF2 Q33958241-C135AAD0-304C-46FC-9D43-10066CD2CED2 Q33980640-3A626768-10A7-40DB-BB4B-AA7F739D73BB Q34445021-85CCB5E6-D639-4ECA-83D7-779353FC85B7 Q34704153-02616AD5-285C-4AB6-BF06-8C119B4B70B2 Q35119617-8BDC2D33-E84E-4C11-B2C4-222567700E22 Q35125109-AC0276E5-5A1B-4BBD-A2F1-7F70EC78CCB8 Q36001600-A90A3D22-7461-467A-A28E-8E359D0504D6 Q36193915-9F617EDE-59C6-4EA5-ADC9-FDBF811FD12C Q36227293-6EAC1DBF-E156-4BAC-9505-D6E798F922E5 Q36451834-D66D5A10-69DF-49CF-B488-030E8A5DB9D2 Q36966631-FC9CEEF4-9609-4A3C-BBD2-6EE319230759 Q37041779-D426742A-CA93-4F12-A2F7-7F99F240A78C Q37284871-5ACE854B-FCB0-43F7-8248-747122B10E34 Q37299447-638B760E-7183-429B-965C-5F70001BBBDB Q37328470-BFAF9058-1134-41D7-884D-C95D9B615FF7 Q37466992-4C1E003B-D995-4CF0-9799-9EBAF3B83DA7 Q37487771-FAD8434F-BB8C-4F13-A713-F59C82E381C5 Q37499033-9F8AF7DD-2F79-4F2F-8B36-23E7CA562C4B Q37733601-7542A6AD-AF7D-47CD-A77B-2A4922B16E30 Q37896515-7FD58248-A963-4903-8051-3016338D873C Q38016791-EDBEA656-99CC-45F5-9EEF-8A40E633C4AF Q38078791-8283678C-F70A-4DED-8A1F-347073742E02 Q38189727-D6120D8A-CE86-4608-9544-52F6F9AEC425 Q38312630-D5F040B2-355C-47A1-81C1-60AAA020508D Q38335335-206512E3-2C7C-41A2-BE60-A2F8050316B8 Q38359613-974DDDC7-ACBD-41B3-AFCA-D3343FA96299 Q38410593-83D31866-608F-4895-95C8-85E202728F8F Q38461098-ABCC21AB-B081-4011-A257-DB295143648A Q38970176-B04CAB11-0167-4F3D-9AC2-28EEAEA5A35E Q39052041-515D493C-0A17-4E73-AD8B-3B8935B96961 Q40002811-9D84A4A3-E112-440B-8118-4867BDC4C190 Q42457698-1805A9CA-FA38-49F4-9650-08FEBD29E004 Q46017611-F2CF4A39-F5A7-472E-A0CF-91D64A73DC39 Q47166540-ECCC2B13-775C-4725-B846-9C9419700995 Q48144998-A9B7A360-0A89-4C2B-AA22-CBFC301FD481 Q48281091-B39F9529-54A1-42AA-AFF5-F28697669776 Q50553735-E11E7584-11EF-45A4-A8CE-CB6E3900230C Q50566330-3186C9E1-207A-4C6F-ACD5-158FA7A293AB Q52573559-E626AD64-1676-42E9-BBDE-22DC25E431DD

P2860

Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.

http://www.wikidata.org/entity/Q48190162

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Tau pathology in the olfactory ...... y and apolipoprotein epsilon4.

@en

Tau pathology in the olfactory ...... y and apolipoprotein epsilon4.

@nl

type

label

Tau pathology in the olfactory ...... y and apolipoprotein epsilon4.

@en

Tau pathology in the olfactory ...... y and apolipoprotein epsilon4.

@nl

prefLabel

Tau pathology in the olfactory ...... y and apolipoprotein epsilon4.

@en

Tau pathology in the olfactory ...... y and apolipoprotein epsilon4.

@nl

P1433

Q48190162-0D5FC6A5-486D-485E-8EDF-B7ED7E36DBBE

P1476

Q48190162-1047B2D4-0A72-437A-BADA-2D6B4A2D0D5E

P2093

Q48190162-306BDA92-F732-4986-A000-80A4A8ECA3B5

Q48190162-B35D445F-DC0D-4E74-885D-EFA7551CD9D4

Q48190162-D52C7E27-1529-4064-8424-85E63757D22C

P2860

Q48190162-105A40DF-CF66-48E3-8CCA-C514C6E67EBB

Q48190162-29A13C37-E358-4933-B939-34B522DF59EB

Q48190162-33D48125-9537-4C41-971A-0667F01A28BE

Q48190162-4AD61752-DE9A-4544-A434-AD326743A382

Q48190162-506D4332-2034-4D68-9152-441CAA1ADF8E

Q48190162-575F5989-D8E2-4C23-B1D4-3E00329B288E

Q48190162-635B551B-57FC-4CDA-A3DB-BB7249AB4BF0

Q48190162-6BF57BDC-CFBA-4F65-AB6C-F2A813079F83

Q48190162-7060E972-9175-40C5-9629-2F7D82E99128

Q48190162-78F30FD2-53B2-4C48-B892-16FE69D08E8D

P304

Q48190162-378F7368-FEA8-446C-8E6C-024C729204F5

P31

Q48190162-392AB503-84D5-4639-93AF-1F88548D10CC

P356

Q48190162-2D66CA27-20AB-47CD-91A8-2D3F13DEFD9A

P433

Q48190162-25AFDE1B-2607-447E-BE33-84E6C2A449D2

P478

Q48190162-9ADE03C6-8325-46BE-A569-A7E2592296A2

P50

Q48190162-573CFA29-A1DC-4CB9-B6B1-0564CDBB520C

Q48190162-6E3DAA7D-61A1-45EF-BB7E-7B6A4C002DD6

P577

Q48190162-EA1887FA-A6D6-4455-A62B-59C2C5A7BFA1

P698

Q48190162-21CDCC0D-C71E-4A9A-B584-9C2E787F87B5

P921

Q48190162-74f44fce-1457-4f3a-945b-1ba957bbbdaf

P356

J.1365-2990.2003.00453.X

P1433

Neuropathology and Applied Neurobiology

P1476

Tau pathology in the olfactory ...... y and apolipoprotein epsilon4.

@en

P2093

Cookson N

http://www.w3.org/2001/XMLSchema#string

Graff-Radford NR

http://www.w3.org/2001/XMLSchema#string

Tsuboi Y

http://www.w3.org/2001/XMLSchema#string

P2860

Alpha-synuclein in Lewy bodies

Neuropathological stageing of Alzheimer-related changes

Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology.

Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis.

Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration.

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.

beta-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease.

Odor identification in normal aging and early Alzheimer's disease: effects of retrieval support.

Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status.

Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases.

P304

503-510

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2990.2003.00453.X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Dennis W. Dickson

Zbigniew K Wszolek

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14507342

http://www.w3.org/2001/XMLSchema#string

P921